Bulletin from the extraordinary general meeting in Meda AB (publ)

At the extraordinary general meeting held today, 25 August, 2016, Meda AB (publ) resolved that the board shall, for the period until the end of the next Annual General Meeting, consist of Caroline Dixon, Jacek Glinka and Colleen Ostrowski, with Jacek Glinka as Chairman of the board.

For further inquiries, please contact:

Paula Treutiger, VP Corporate Communications & Sustainability                                     ph: +46 733-666 599                                                                                                                                                                                                                  paula.treutiger@meda.se

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. Find out more, visit www.meda.se.

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.